How to overcome the issue of poorly reported clinical trial outcomes
A number of initiatives developed to prevent researchers from only reporting the most impressive outcomes of clinical trials are explored in an opinion piece from The BMJ.
The elimination of negative study results: reporting and citation bias
Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
New EU trials tracker reveals that half of European clinical trials have broken reporting rules
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Inferential statistics and false conclusions: is the p value to blame?
Significance testing and p values are widely used in medical publications, but just how meaningful are they?
Meeting report: summary of the 14th Annual Meeting of ISMPP – Part 2
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Clinical trial transparency: are non-commercial funders lagging behind industry sponsors?
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
A new series from The BMJ highlights unreported trials
A new, regular series in The BMJ will highlight a different unreported clinical trial every week, with the intention of improving reporting rates.
International Women’s Day 2018: how will you Press for Progress?
Join other medical, science, and publications professionals worldwide to #PressforProgress on #IWD2018 and beyond.
What proportion of clinical trial data is reported? TrialsTracker launches new monitoring tool
The FDAAA 2007 requires clinical trials to make results publicly available 12 months after study completion. A new tool from TrialsTracker provides a live online report on compliance.
Meeting report: summary of day 1 of the 2018 European ISMPP Meeting
Missed ISMPP EU 2018? Read our meeting report to get up to speed!
Calling All Medical Publication Professionals – Join Us at the 2018 European ISMPP Meeting
Online Registration Until January 3, 2018! Medical publication professionals from the pharmaceutical industry, medical communication agencies, journals, academia, etc., are all welcome to participate in the 2018 European Meeting of … Continue Reading Calling All Medical Publication Professionals – Join Us at the 2018 European ISMPP Meeting
Celebrating the positives in negative results
Although most scientists understand the importance of publishing all study data, it remains a fact that articles describing data that do not confirm the author’s hypothesis are less likely to … Continue Reading Celebrating the positives in negative results
Registered Reports: enhancing transparency and reproducibility in scientific publication
Recently, F1000Research published the first article of their new Registered Report initiative. The publisher is the first to go a step further with this publication format, combining the Registered Report … Continue Reading Registered Reports: enhancing transparency and reproducibility in scientific publication
‘Bad science’ and how new ideas in scientific publishing can combat it
In a position paper published in The Leadership Quarterly earlier this year, Professor John Antonakis described factors that he believes are stifling the production of useful scientific research. In response to … Continue Reading ‘Bad science’ and how new ideas in scientific publishing can combat it
Meeting report: Summary of Day 2 of the 2017 European #ISMPP Meeting
Over two days last month (17-18 January, 2017), around 250 delegates and exhibitors attended the 2017 European meeting of the International Society for Medical Publication Professionals (ISMPP) in London. The … Continue Reading Meeting report: Summary of Day 2 of the 2017 European #ISMPP Meeting
TrialsTracker attempts to identify trials with potentially unreported results
It has been suggested that a sizeable number of registered clinical trials fail to report their results, and that negative or null results are especially likely to remain unpublished. To help tackle … Continue Reading TrialsTracker attempts to identify trials with potentially unreported results